Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.
Ontology highlight
ABSTRACT: Chagas disease, caused by Trypanosoma cruzi, is a devastating parasitic infection affecting millions of people. Although many efforts have been made for the development of immunotherapies, there is no available vaccine against this deadly infection. One major hurdle for the rational approach to develop a T. cruzi vaccine is the limited information about the proteins produced by different phylogenetic lineages, strains, and stages of the parasite. Here, we have adapted a 1D nanoHPLC system to perform online 2D LC-MS/MS, using the autosampler to inject the eluting salt solutions in the first dimension separation. The application of this methodology for the proteomic analysis of the infective trypomastigote stage of T. cruzi led to the identification of 1448 nonredundant proteins. Furthermore
SUBMITTER: Nakayasu ES
PROVIDER: S-EPMC3253764 | biostudies-literature | 2012 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA